This compound is a pharmaceutical intermediate with a thiazole core and a nitrile-substituted phenol group. Its structure features aromatic rings, an ester functional group, and moderate polarity, indicating potential utility in organic synthesis and drug development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
pharmaceutical intermediate
(3aR,7aS)-rel-Octahydro-1H-isoindole hydrochloride
pharmaceutical intermediate
Alogliptin Impurity 07
pharmaceutical intermediate
3-quinuclidinol
pharmaceutical intermediate
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
pharmaceutical intermediate
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
pharmaceutical intermediate
Febuxostat
pharmaceutical raw material
ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
WTMZFYPEMMFHPR-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)O)C#N)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.